Evolution of the human immunodeficiency virus type 2 envelope in the first years of infection is associated with the dynamics of the neutralizing antibody response
Background: Differently from HIV-1, HIV-2 disease progression usually takes decades without antiretroviral therapy and the majority of HIV-2 infected individuals survive as elite controllers with normal CD4+ T cell counts and low or undetectable plasma viral load. Neutralizing antibodies (Nabs) are...
Autor principal: | |
---|---|
Outros Autores: | , , , , , , , , , , , , |
Formato: | article |
Idioma: | eng |
Publicado em: |
2018
|
Assuntos: | |
Texto completo: | https://doi.org/10.1186/1742-4690-10-110 |
País: | Portugal |
Oai: | oai:run.unl.pt:10362/30200 |